Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2008 March;60(1) > Minerva Urologica e Nefrologica 2008 March;60(1):31-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  CLINICAL UPDATE ON PROSTATIC CANCER


Minerva Urologica e Nefrologica 2008 March;60(1):31-9

language: English

Robotic assisted laparoscopic radical prostatectomy: evolution and outcomes

Nguyen M. M., Wang Z.

Division of Urology University of Wisconsin, Madison, WI, US


PDF  


Robotic assisted laparoscopic prostatectomy (RALP) is rapidly gaining acceptance in the urologic community as an effective treatment modality for the treatment of localized prostate cancer. For the open surgeon, this technology assists in the transition to laparoscopic-based surgery. With early stage cancer, the absence of tactile feedback appears to be offset by the superior visualization and instrumentation that the daVinci robot™ (Intuitive Surgical, Sunnyvale, CA, USA) provides. Economical considerations also appear to be outweighed by patient demand and benefits. Short-term perioperative, functional, and oncological outcomes all appear to be equivalent to the gold standard, open radical retropubic prostatectomy. In conclusion, RALP is an excellent option for patients considering prostate cancer treatment and should be part of the urologic surgeon’s armamentarium.

top of page

Publication History

Cite this article as

Corresponding author e-mail